6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
7m ago	Yapi ve Kredi Bankasi : Successful issuance of 500 million US$ perpetual Additional Tier 1 Capital Transaction
12m ago	Crown Castle Names Kris Hinson as Chief Commercial Officer and Mark Lennon as Chief Information Officer
17m ago	Hovnanian Enterprises Reports Fiscal 2026 Second Quarter Results
17m ago	LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit
17m ago	KKR Sells CIRCOR Aerospace to Parker Hannifin for $2.55 Billion

About

78.77USD+2.32 +3.03%

Closed • Updated at 13:33 GMT+00:00

Market Cap$9.80B

Volume2.38M

Beta0.58

RSI65.38

Gross Margin87.00%

Health TechnologyPharmaceuticals: Major

Cytokinetics, Incorporated — investor relations, events, news, and company updates on 6ix.

Latest News

Cytokinetics Announces New Data Related to MYQORZO® (aficamten) at ESC Heart Failure 2026

Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $805 Million

Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock

Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update

Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy

Community Chat

Ask AI